COVID-19 Funds Flow To Startup In Bid To Restore US Pharmaceutical Manufacturing

 
• By Bowman Cox

Trump administration infuses Phlow with potentially $800m-plus for fully integrated domestic manufacture of essential medicines for COVID-19 and other crises. Key figures in new approaches to securing drugs and experts on China helped frame the project’s approach.

PS2005_Pharma Factory_266841464_1200
domestic us pharma manufacturing startup funded • Source: Shutterstock

More from Manufacturing

More from Compliance